{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Arrazola MS"],"funding":["Fondo Nacional de Desarrollo Científico y Tecnológico","Biotechnology and Biological Sciences Research Council","Michael J. Fox Foundation for Parkinson's Research"],"pagination":["e13814"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10186608"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["22(5)"],"pubmed_abstract":["Age is the main risk factor for the development of neurodegenerative diseases. In the aged brain, axonal degeneration is an early pathological event, preceding neuronal dysfunction, and cognitive disabilities in humans, primates, rodents, and invertebrates. Necroptosis mediates degeneration of injured axons, but whether necroptosis triggers neurodegeneration and cognitive impairment along aging is unknown. Here, we show that the loss of the necroptotic effector Mlkl was sufficient to delay age-associated axonal degeneration and neuroinflammation, protecting against decreased synaptic transmission and memory decline in aged mice. Moreover, short-term pharmacologic inhibition of necroptosis targeting RIPK3 in aged mice, reverted structural and functional hippocampal impairment, both at the e"],"journal":["Aging cell"],"pubmed_title":["Necroptosis inhibition counteracts neurodegeneration, memory decline, and key hallmarks of aging, promoting brain rejuvenation."],"pmcid":["PMC10186608"],"funding_grant_id":["BBS/E/D/10002071","1190620","EastBio","11220120","1150766","17303","1200255"],"pubmed_authors":["Quiroz G","Bernales S","Ureta G","Wishart TM","Veliz-Valverde F","Eaton SL","Huerta H","Arrazola MS","Cerpa W","Lira M","Iqbal S","Court FA","Cardenas JC","Lamont DJ"],"additional_accession":[]},"is_claimable":false,"name":"Necroptosis inhibition counteracts neurodegeneration, memory decline, and key hallmarks of aging, promoting brain rejuvenation.","description":"Age is the main risk factor for the development of neurodegenerative diseases. In the aged brain, axonal degeneration is an early pathological event, preceding neuronal dysfunction, and cognitive disabilities in humans, primates, rodents, and invertebrates. Necroptosis mediates degeneration of injured axons, but whether necroptosis triggers neurodegeneration and cognitive impairment along aging is unknown. Here, we show that the loss of the necroptotic effector Mlkl was sufficient to delay age-associated axonal degeneration and neuroinflammation, protecting against decreased synaptic transmission and memory decline in aged mice. Moreover, short-term pharmacologic inhibition of necroptosis targeting RIPK3 in aged mice, reverted structural and functional hippocampal impairment, both at the e","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 May","modification":"2025-04-18T15:12:45.7Z","creation":"2025-04-07T01:51:48.785Z"},"accession":"S-EPMC10186608","cross_references":{"pubmed":["36973898"],"doi":["10.1111/acel.13814"]}}